Box score
Vesalius Longevity Labs Inc.
Reported $6.5M sold in a new Form D filed November 18, 2026 (Vancouver, outside the US).
- Biggest raise
- $6.5M filed Nov 18, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Vancouver, outside the US
- Season rank
- #293 of 1,212 in the Bio & Health League; #2634 of 11,716 overall (2026)
- Entity
- Corporation
Form D filings since 2024 2
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-11-18 | New notice | $6.5M | $13.5M | SEC |
| 2026-11-03 | New notice not ranked | $30.1M | $30.1M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2131865.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Pulsenmore Ltd. rookie provisional | Bio & Health | $7.5M |
| 2 | Vesalius Longevity Labs (SPV) Inc. | Bio & Health | $6.7M |
| 3 | Regentis Biomaterials Ltd. rookie | Bio & Health | $6.5M |
| 4 | Federated Biologics Inc. rookie | Bio & Health | $6M |
| 5 | EnteroBiotix LTD | Bio & Health | $5.3M |
| 6 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |